Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Severe Mental Illness”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05888961
What this trial is testing

Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials

Who this might be right for
Cognitive Disorders
Centre Hospitalier Universitaire Dijon 74
Post-approval studies (Phase 4)UnknownNCT05430867
What this trial is testing

Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
TreatmentEfficacySafety+1 more
First Affiliated Hospital Xi'an Jiaotong University 150
Large-scale testing (Phase 3)Study completedNCT01152554
What this trial is testing

Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive DisorderMDDDepression
AstraZeneca 813
Large-scale testing (Phase 3)Study completedNCT01715805
What this trial is testing

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Forest Laboratories 1,022
Not applicableStudy completedNCT01446692
What this trial is testing

Badalona Major Depressive Disorder Database Study

Who this might be right for
Major Depressive Disorder
AstraZeneca 2,260
Post-approval studies (Phase 4)UnknownNCT04352621
What this trial is testing

Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)

Who this might be right for
Major Depressive Disorder
University of Cincinnati 20
Not applicableStudy completedNCT02004145
What this trial is testing

Trial of a Positive Psychology Intervention in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Massachusetts General Hospital 65
Not applicableUnknownNCT01488266
What this trial is testing

Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Korea University 90
Not applicableStudy completedNCT03360695
What this trial is testing

Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer

Who this might be right for
CancerSevere Major DepressionSchizophrenia+5 more
Massachusetts General Hospital 185
Large-scale testing (Phase 3)Study completedNCT00097916
What this trial is testing

An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Forest Laboratories 34
Not applicableStudy completedNCT03915821
What this trial is testing

Memory Changes in Patients With Major Depression Disorder Treated With ECT

Who this might be right for
Depressive Disorder
Assiut University 60
Large-scale testing (Phase 3)Looking for participantsNCT06958692
What this trial is testing

A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder (MDD)
CSPC Ouyi Pharmaceutical Co., Ltd. 388
Post-approval studies (Phase 4)Looking for participantsNCT07105111
What this trial is testing

Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Neurocrine Biosciences 100
Early research (Phase 1)Ended earlyNCT03523767
What this trial is testing

Effect of Systemic Inflammation on Emotion and Cognition in Patients With Mood Disorder - A Vaccine Study

Who this might be right for
Major Depressive Disorder
The University of Texas Health Science Center, Houston 19
Testing effectiveness (Phase 2)UnknownNCT05280015
What this trial is testing

Microbiotherapy in Characterized Depressive Disorder

Who this might be right for
DepressionDepressive DisorderDepressive Disorder, Major
Centre Hospitalier Universitaire de Besancon 92
Large-scale testing (Phase 3)Study completedNCT02358343
What this trial is testing

A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}

Who this might be right for
DepressionEnd Stage Renal Disease
University of Washington 184
Not applicableStudy completedNCT02548949
What this trial is testing

Korean Post Marketing Surveillance to Observe Effectiveness and Safety of PRISTIQ

Who this might be right for
Major Depressive Disorder
Pfizer 700
Large-scale testing (Phase 3)Looking for participantsNCT05850689
What this trial is testing

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Intra-Cellular Therapies, Inc. 470
Not applicableLooking for participantsNCT06896279
What this trial is testing

Study on the Effectiveness and Safety of Temporal Interference Stimulation in Treating Patients With Severe Consciousness Disorders

Who this might be right for
Disorder of ConsciousnessTemporal Interference Stimulation
Huashan Hospital 20
Large-scale testing (Phase 3)Study completedNCT02951988
What this trial is testing

Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Naurex, Inc, an affiliate of Allergan plc 1,304
Next Page